炎症与缺血性脑卒中的关系

[1] Carotid and femoral atherosclerosis, cardiovascular risk factors and C‐reactive protein in relation to smokeless tobacco use or smoking in 58‐year‐old men[J] . K.Wallenfeldt,J.Hulthe,L.Bokemark,J.Wikstrand,B.Fagerberg.Journal of Internal Medicine . 2001 (6)

[2] Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Study[J] . Natalia S. Rost,Philip A. Wolf,Carlos S. Kase,Margaret Kelly-Hayes,Halit Silbershatz,Joseph M. Massaro,Ralph B. D’Agostino,Carl Franzblau,Peter W.F. Wilson.Stroke: Journal of the American Heart Association . 2001 (11)

[3] Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease [J]. CIRCULATION, 2000, 102 (09) : 1000 - 1006

[4] HMG-CoA reductase inhibitors （statins）: A promising approach to stroke prevention[J] . David C. Hess,Andrew M. Demchuk,Lawrence M. Brass,Frank M. Yatsu.Neurology . 2000 (4)

[1] Carotid and femoral atherosclerosis, cardiovascular risk factors and C‐reactive protein in relation to smokeless tobacco use or smoking in 58‐year‐old men[J] . K.Wallenfeldt,J.Hulthe,L.Bokemark,J.Wikstrand,B.Fagerberg.Journal of Internal Medicine . 2001 (6)

[2] Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Study[J] . Natalia S. Rost,Philip A. Wolf,Carlos S. Kase,Margaret Kelly-Hayes,Halit Silbershatz,Joseph M. Massaro,Ralph B. D’Agostino,Carl Franzblau,Peter W.F. Wilson.Stroke: Journal of the American Heart Association . 2001 (11)

[3] Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease [J]. CIRCULATION, 2000, 102 (09) : 1000 - 1006

[4] HMG-CoA reductase inhibitors （statins）: A promising approach to stroke prevention[J] . David C. Hess,Andrew M. Demchuk,Lawrence M. Brass,Frank M. Yatsu.Neurology . 2000 (4)